Cargando…

Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy

Antibody-directed enzyme prodrug therapy (ADEPT) delivers chemotherapeutic agents in high concentration to tumor tissue, while minimizing systemic drug exposure. ADEPT has been reported to be an attractive approach for improving the efficacy of cancer therapy. A previously reported β-lactamase was f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaoliang, Wang, Hao, Shi, Peiji, Meng, Ai-min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986274/ https://www.ncbi.nlm.nih.gov/pubmed/24748803 http://dx.doi.org/10.2147/OTT.S59346

Ejemplares similares

A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy
por: Wang, Hao, et al.
Publicado: (2015)

Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

The biogenesis of β-lactamase enzymes
por: Kaderabkova, Nikol, et al.
Publicado: (2022)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017)

PDEPT: polymer-directed enzyme prodrug therapy
por: Satchi, R, et al.
Publicado: (2001)

Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
por: van Haren, Matthijs J., et al.
Publicado: (2021)

Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin
por: Zhou, Jie, et al.
Publicado: (2020)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells
por: Zhou, Ru, et al.
Publicado: (2022)

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
por: Green, Laura K, et al.
Publicado: (2013)

In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy
por: Al-mansoori, Layla, et al.
Publicado: (2020)

Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol
por: Tupper, J, et al.
Publicado: (2004)

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
por: Martin, Stacy E., et al.
Publicado: (2014)

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2021)

Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material
por: Webley, S D, et al.
Publicado: (2001)

Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug
por: Evans, Lindsay E., et al.
Publicado: (2019)

Human metallo-β-lactamase enzymes degrade penicillin
por: Diene, Seydina M., et al.
Publicado: (2019)

Substrate Mediated Enzyme Prodrug Therapy
por: Fejerskov, Betina, et al.
Publicado: (2012)

Enzyme Models—From Catalysis to Prodrugs
por: Breijyeh, Zeinab, et al.
Publicado: (2021)

Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data.
por: Baxter, L. T., et al.
Publicado: (1996)

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.
por: Rogers, G. T., et al.
Publicado: (1995)

Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
por: Roemhild, Karolin, et al.
Publicado: (2022)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
por: Monks, N R, et al.
Publicado: (2000)

Short communication: A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy
por: Deckert, P M, et al.
Publicado: (2003)

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
por: Mayer, A, et al.
Publicado: (2004)

Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282
por: O’Donnell, John, et al.
Publicado: (2020)

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability
por: Makena, Anne, et al.
Publicado: (2015)

Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
por: Theys, J, et al.
Publicado: (2006)

A metallo-β-lactamase enzyme for internal detoxification of the antibiotic thienamycin
por: Diene, Seydina M., et al.
Publicado: (2021)

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
por: Francis, R J, et al.
Publicado: (2002)

The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
por: Green, Laura K., et al.
Publicado: (2013)

Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity
por: Oueslati, Saoussen, et al.
Publicado: (2019)

Prodrug converting enzyme gene delivery by L. monocytogenes
por: Stritzker, Jochen, et al.
Publicado: (2008)

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
por: Fuhrmann, Gregor, et al.
Publicado: (2018)

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
por: Markovic, Milica, et al.
Publicado: (2020)

Fusion Enzymes Containing HSV-1 Thymidine Kinase Mutants and Guanylate Kinase Enhance Prodrug Sensitivity In Vitro and In Vivo
por: Ardiani, Andressa, et al.
Publicado: (2009)

Polymeric Nanovectors Incorporated with Ganciclovir and HSV-tk Encoding Plasmid for Gene-Directed Enzyme Prodrug Therapy
por: Sawdon, Alicia J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_52c3s2fk8gs17t7e353otk859m